July 10, 2020
Sterling Bay and its life sciences division, The Labs, finalized a lease with biotechnology startup Vanqua Bio at the recently redeveloped 2430 N. Halsted in Lincoln Park. Vanqua Bio plans to move into its new space in January 2021.
“Just last year, we launched The Labs by Sterling Bay, a first-in-market solution for developing much-needed, scalable lab space in Chicago’s metro area,” said Andy Gloor, CEO of Sterling Bay. “With the signing of Vanqua Bio, a startup born right here in our hometown, we are once again validated in our belief that Chicago can fulfill its potential as the next world-class hub for medical innovation by simply investing in the resources necessary to retain and attract the most brilliant minds in biotech.”
CBRE EVP David Saad represented Sterling Bay in the Vanqua Bio deal. Earlier this year, Sterling Bay announced its first lease at 2430 N. Halsted, signing Exicure, Inc.
For comments, questions or concerns, please contact Paul Bubny